Skip to content
10-K

Annual Report

CATALENT PHARMA SOLUTIONS, INC.

0001416083-13-000014

← back to feed
Filed
Sep 10, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Sep 3, 2013 100 sh
Capex FY 2013 · Jun 30, 2013 $122.5M
Capex FY 2013 · Jun 30, 2012 $104.2M
Capex FY 2013 · Jun 30, 2011 $87.3M
Operating Cash Flow FY 2013 · Jun 30, 2013 $137.7M
Operating Cash Flow FY 2013 · Jun 30, 2012 $87.9M
Operating Cash Flow FY 2013 · Jun 30, 2011 $99.7M
Long Term Debt FY 2013 · Jun 30, 2013 $2.66B
Long Term Debt FY 2013 · Jun 30, 2012 $2.64B
Cash And Equivalents FY 2013 · Jun 30, 2013 $106.4M
Cash And Equivalents FY 2013 · Jun 30, 2012 $139M
Cash And Equivalents FY 2013 · Jun 30, 2011 $205.1M
Cash And Equivalents FY 2013 · Jun 30, 2010 $164M
Stockholders Equity FY 2013 · Jun 30, 2013 −$410.3M
Stockholders Equity FY 2013 · Jun 30, 2012 −$350.7M
Stockholders Equity FY 2013 · Jun 30, 2011 −$209.9M
Stockholders Equity FY 2013 · Jun 30, 2010 −$263.5M
Current Liabilities FY 2013 · Jun 30, 2013 $410.3M
Current Liabilities FY 2013 · Jun 30, 2012 $439.3M
Current Assets FY 2013 · Jun 30, 2013 $677.9M
Current Assets FY 2013 · Jun 30, 2012 $704.7M
Total Assets FY 2013 · Jun 30, 2013 $3.06B
Total Assets FY 2013 · Jun 30, 2012 $3.14B
Sga Expense FY 2013 · Jun 30, 2013 $340.6M
Sga Expense FY 2013 · Jun 30, 2012 $348.1M
Sga Expense FY 2013 · Jun 30, 2011 $288.3M
Net Income FY 2013 · Jun 30, 2013 −$46.7M
Net Income FY 2013 · Jun 30, 2012 −$40.4M
Net Income FY 2013 · Jun 30, 2011 −$54M
Operating Income FY 2013 · Jun 30, 2013 $204.4M
Operating Income FY 2013 · Jun 30, 2012 $198M
Operating Income FY 2013 · Jun 30, 2011 $186.1M
Gross Profit FY 2013 · Jun 30, 2013 $568.6M
Gross Profit FY 2013 · Jun 30, 2012 $558.6M
Gross Profit FY 2013 · Jun 30, 2011 $502.1M
Cost Of Revenue FY 2013 · Jun 30, 2013 $1.23B
Cost Of Revenue FY 2013 · Jun 30, 2012 $1.14B
Cost Of Revenue FY 2013 · Jun 30, 2011 $1.03B
Revenue FY 2013 · Jun 30, 2013 $1.8B
Revenue FY 2013 · Jun 30, 2012 $1.69B
Revenue FY 2013 · Jun 30, 2011 $1.53B